Develops and commercializes cell-based technologies built on a proprietary 3D cell-expansion platform, including regenerative medicine and immunotherapy product candidates and cellular-agriculture solutions. Generates current revenue primarily from CDMO process/product development services and AgTech proof-of-concept service fees, while advancing cultivated food platforms for future licensing and partnerships.
